ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC Feb. 26, 2021
Salarius initiates expansion stage for phase I/II study of seclidemstat in Ewing sarcoma Feb. 25, 2021
RSS